Table 2.
Richness index | Diversity indices | ||||||||
---|---|---|---|---|---|---|---|---|---|
Chao 1 | Simpson | Shannon | |||||||
Dosage group | TT1 | WD2 | Total3 | TT1 | WD2 | Total3 | TT1 | WD2 | Mean3 |
Control | 278.17 | 182.67 | 230.42 | 0.71 | 0.67 | 0.69 | 3.41 | 3.05 | 3.23 |
Low | 171.67 | 123.83 | 147.75 | 0.60 | 0.50 | 0.55 | 2.54 | 1.80 | 2.17 |
PK/PD | 178.67 | 194.83 | 186.75 | 0.51 | 0.74 | 0.63 | 2.19 | 3.16 | 2.68 |
High | 265.17 | 240.17 | 240.17 | 0.68 | 0.55 | 0.62 | 3.46 | 2.40 | 2.93 |
TT, treatment; WD, withdrawal. 1Fecal samples collected within the three treatment periods (day 8, 14, 25, 28, 39, and 42) were considered as repeats for treatment. Values are means (n = 6). 2Fecal samples collected within the three withdrawal periods (day 18, 21, 32, 35, 46, and 49) were considered as repeats for withdrawal. Values are means (n = 6). 3Mean values of the community metrics calculated from the total 12 samples collected post medication in each group. Values are means (n = 12).